Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?

Written by Journal of Comparative Effectiveness Research

In this article, the authors investigate the differences between clinican- and patient-reported outcomes in oncology trials. This research article, from the Journal of Comparative Effectiveness Research, is free to access exclusively for The Evidence BaseĀ® members. Although cancer treatments are continuously improving, they all impact patient's well-being and daily functioning. Even modern anti-cancer targeted therapies, such as small molecule inhibitors, generate side effects and adverse events (AEs) that need to be properly managed in clinical practice.Traditionally, ratings of AEs in randomized controlled trials (RCTs) have relied upon standardized coding systems, such as the National Cancer Institute (NCI) Common Terminology Criteria...

To view this content, please register now for access

It's completely free